Testing the LILAC method for lipoprotein(a) education
Part of Heart & circulation clinical trials.
This trial tests a new method called LILAC to help people learn about and manage high levels of lipoprotein(a), a type of fat in the blood. It is for anyone 16 or older who attends educational events or is part of a health group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You are a student or participant at a higher learning institute, or you attend educational talks by Dr. Loh.
- You are a patient or member of the public attending a lipid awareness event.
- You are in a patient support group or advocacy network.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether simple electronic letters can motivate people with heart disease to better manage their health, especially their cholesterol levels. If you have high Lp(a) — a type of cholesterol linked to heart risk — you may also get a special letter about that.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This is a registry study that looks at how common high lipoprotein(a) levels are. It helps researchers understand this condition better.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
This study looks at a blood marker called Lp(a) in adults who have lymphedema. The goal is to understand whether checking Lp(a) is important for people with this condition.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.